메뉴 건너뛰기




Volumn 20, Issue 6, 2001, Pages 628-630

Safety and tolerance of palivizumab administration in a large northern hemisphere trial

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Infectious disease; Monoclonal antibodies; Premature infants; Respiratory disease; Respiratory syncytial virus

Indexed keywords

PALIVIZUMAB;

EID: 0034971499     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200106000-00018     Document Type: Article
Times cited : (33)

References (7)
  • 4
    • 0031683919 scopus 로고    scopus 로고
    • Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
    • (1998) Pediatrics , vol.102 , pp. 531-537
  • 5
    • 0031729747 scopus 로고    scopus 로고
    • Prevention of respiratory syncytial virus infection: Indications for the use of palivizumab and update on the use of RSV-IVIG
    • (1998) Pediatrics , vol.102 , pp. 1211-1216


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.